This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Citizens analyst James McCanless initiated coverage on Century Communities Inc (NYSE:CCS) with a Market Outperform rating and announced a price target of $92. Century Communities shares closed at $66.26 on Tuesday. See how other analysts view this stock.
• Chardan Capital analyst Janani Sundararajan initiated coverage on Alumis Inc (NASDAQ:ALMS) with a Buy rating and announced a price target of $37. Alumis shares closed at $26.06 on Tuesday. See how other analysts view this stock.
• Rosenblatt analyst Mike Genovese initiated coverage on Credo Technology Group Holding Ltd (NASDAQ:CRDO) with a Neutral rating and announced a price target of $170. Credo Technology shares closed at $153.22 on Tuesday. See how other analysts view this stock.
• Guggenheim analyst Brad Canino initiated coverage on Crescent Biopharma Inc (NASDAQ:CBIO) with a Buy rating and announced a price target of $35. Crescent Biopharma shares closed at $13.98 on Tuesday. See how other analysts view this stock.
• Ladenburg Thalmann analyst Jon Hickman initiated coverage on Amaze Holdings Inc (AMEX:AMZE) with a Buy rating and announced a price target of $3. Amaze Holdings shares closed at $0.42 on Tuesday. See how other analysts view this stock.

Considering buying CBIO stock? Here’s what analysts think:

Photo via Shutterstock